Chemoinformaics analysis of gamma-Glutamyl-beta-cyanoalanine
| Molecular Weight | 243.219 | nRot | 7 |
| Heavy Atom Molecular Weight | 230.115 | nRig | 4 |
| Exact Molecular Weight | 243.086 | nRing | 0 |
| Solubility: LogS | -1.266 | nHRing | 0 |
| Solubility: LogP | -3.528 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 31.0083 |
| nHD | 4 | BPOL | 16.2157 |
| QED | 0.431 |
| Synth | 3.116 |
| Natural Product Likeliness | 0.272 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.059 |
| HIA | 0.824 |
| CACO-2 | -6.331 |
| MDCK | 0.00391069 |
| BBB | 0.399 |
| PPB | 0.127954 |
| VDSS | 0.384 |
| FU | 0.810669 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.019 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.027 |
| CYP2c9-inh | 0.045 |
| CYP2c9-sub | 0.325 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.078 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.003 |
| CL | 2.579 |
| T12 | 0.821 |
| hERG | 0.01 |
| Ames | 0.023 |
| ROA | 0.005 |
| SkinSen | 0.269 |
| Carcinogencity | 0.125 |
| EI | 0.064 |
| Respiratory | 0.542 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.91758 |